The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

UK trumpets life sciences post-Brexit ‘sector deal’

Other projects highlighted in the document include a $100m contract from The Medicines Company to test a cholesterol-lowering drug at the University of Oxford’s clinical trials unit, a £40m ... This ecosystem will deliver for everyone, ”he added.

The Medicines Company strengthens board of directors

The Medicines Company strengthens board of directors. Paris Panayiotopoulos joins from ARIAD Pharmaceuticals. ... He said: “I am delighted to be joining The Medicines Company, especially at such an important time.

AZ gets EU green light for new antibiotic Zavicefta

The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of serious Gram-negative bacterial infections requiring hospitalization. ... The Medicines Company also has a candidate called RPXZ7009 in phase III trials

Deal Watch May 2016

The CRL refers to a manufacturing issue. ZS-9 was acquired when the company purchased ZS Pharma for $2.7bn. ... 911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Client Partner, Healthcare Brand Communications, London, circa £...: Circa £55K

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Medical Writer, Healthcare Advertising: £35 - £45, 000 benefits

Account Manager: £40, 000 - £45, 000 benefits

Editorial Director – Medical Education (MedComms): Neg

Account Director – Creative Healthcare Communications: Competative

Senior Account Manager – Medical Education – Boutique Agency: Salary TBC

Science Writer – Healthcare Advertising: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Manager – Strategic Pharma Consultancy – Surrey: Salary TBC

Account Director, Training & Medical Communications, London: Competitive Salary

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Scientific Engagement Director: Salary will be dependant on experience

Client Services Director – Healthcare Advertising - London: Neg

Senior Account Director or Business Unit Director, Healthcare Ad...: C£60, 000 – £70, 000 benefits

SMW – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Delivery Manager/ Head of Delivery – Executive Search: Neg

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Senior Strategic Planner, Healthcare Brand Communications, Londo...: Competitive Salary

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Medical Writer - Medical Communications: £30, 000 - £40, 000 according to skills and experience plus benefits

Multi-Channel Account Managers - Road / Homebased – Full or Part...: Competitive salary

Australian Flu and the dilemma of naming diseases: ...
Wearables and Healthcare: What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?: Businesses can no longer afford to push ahead with the traditional Key Account Management model....